Tag: Medicare Part B reimbursement
Biosimilars are billed differently than generics under Medicare Part B. Each has its own HCPCS code and payment rate based on its ASP plus 6% of the reference product’s price. This system encourages biosimilar entry but doesn’t strongly incentivize switching. Learn how billing works and why adoption remains low in the U.S.
Categories
Medications
Archives
Recent-posts
Opioid-Induced Constipation: How to Prevent and Treat It With Prescription Options
Dec, 19 2025
Breastfeeding Medication Timing: How to Reduce Infant Drug Exposure
Dec, 4 2025
2025 Alternatives for Prelone: A Practical Guide
Feb, 28 2025
Pulmonary Function Tests: How to Interpret Spirometry and DLCO Results
Dec, 9 2025
Continuing Education for Doctors: Staying Current on Generic Medications
Mar, 16 2026